Candriam SCA’s ESSA Pharma EPIX Stock Holding History

Candriam SCA’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-417,532	Closed	-$760K	–	871
2022 Q3	$760K	Sell	417,532 -149,811	-26%	-$395K	0.01%	769
2022 Q2	$1.79M	Sell	567,343 -20,725	-4%	-$116K	0.01%	527
2022 Q1	$3.63M	Sell	588,068 -38,208	-6%	-$336K	0.02%	411
2021 Q4	$8.89M	Buy	626,276 +325,751	+108%	+$3.63M	0.06%	278
2021 Q3	$2.4M	Hold	300,525	–	–	0.02%	547
2021 Q2	$8.59M	Buy	300,525 +300,508	+1,767,694%	+$8.74M	0.06%	309
2021 Q1	$0	Buy	+17	New	+$395	﹤0.01%	810

Other funds holding EPIX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Ally Bridge Group New York $101M AUM 249.88% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return